DSNKY News and Press, Daiichi Sankyo Co Ltd Sponsored ADR Level 1 From 04/26/24

2024-04-26 12:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

2024-04-25 23:50:27 ET Daiichi Sankyo Company, Limited (DSKYF) Q4 2023 Earnings Call Transcript April 25, 2024 02:00 AM ET Company Participants Kentaro Asakura - VP of Corporate Communications Department Hiroyuki Okuzawa - Representative Director, President and COO ...

2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...

2024-04-25 08:37:36 ET More on AstraZeneca AstraZeneca: What The Market's Missing What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals 5 Reasons AstraZeneca Stock Can Rise In 2024 AstraZeneca beats top-line and bottom-line estimates; ...

2024-04-24 10:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio meaningfully beat the benchmark MSCI EAFE Index, as well as the seconda...

2024-04-24 09:30:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio solidly outperformed the MSCI AC World Index. Holdings in health ca...

2024-04-10 05:49:03 ET Roche ( OTCQX:RHHBY ) has obtained CE Mark for its pre-diluted VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx test.... Read the full article on Seeking Alpha For further details see: Roche companion diagnostic test wins CE Mark to i...

2024-04-09 08:54:46 ET More on Vincerx Pharma Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06 Seeking Alpha’s Quant Rating on Vincerx Pharma Historical earnings data for Vincerx Pharma Financial information for Vincerx Pharma Read the full a...

2024-04-02 16:39:37 ET Summary After a forgettable last year, Merck & Co., Inc.'s stock price is up 20% YTD, supported by approvals, a positive outlook for 2024, and an attractive forward P/E. Keytruda, the company's top-selling treatment, received approval from the European C...

2024-04-02 08:16:01 ET AstraZeneca ( NASDAQ: AZN ) and Daiichi Sankyo’s ( OTCPK:DSNKY ) ( OTCPK:DSKYF ) biologics license application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the U.S. for patients with previously treated metastatic HR-posit...